Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies

Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit

A. Paul Mould, Janet A. Askari, Shin Ichi Aota, Kenneth M. Yamada, Atsushi Irie, Yoshikazu Takada, Helen J. Mardon, Martin J. Humphries

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The high affinity interaction of integrin α5β1 with the central cell binding domain (CCBD) of fibronectin requires both the Arg-Gly-Asp (RGD) sequence (in the 10th type III repeat) and a second site (in the adjacent 9th type III repeat) which synergizes with RGD. We have attempted to map the fibronectin binding interface on α5β1 using monoclonal antibodies (mAbs) that inhibit ligand recognition. The binding of two anti-α5 mAbs (P1D6 and JBS5) to α5β1 was strongly inhibited by a tryptic CCBD fragment of fibronectin (containing both synergy sequence and RGD) but not by GRGDS peptide. Using recombinant wild type and mutated fragments of the CCBD, we show that the synergy region of the 9th type III repeat is involved in blocking the binding of P1D6 and JBS5 to α5β1. In contrast, binding of the anti-β1 mAb P4C10 to α5β1 was inhibited to a similar extent by GRGDS peptide, the tryptic CCBD fragment, or recombinant proteins lacking the synergy region, indicating that the RGD sequence is involved in blocking P4C10 binding. P1D6 inhibited the interaction of a wild type CCBD fragment with α5β1 but bad no effect on the binding of a mutant fragment that lacked the synergy region. The epitopes of P1D6 and JBS5 mapped to the NH2- terminal repeats of the α5 subunit. Our results indicate that the synergy region is recognized primarily by the α5 subunit (in particular by its NH2- terminal repeats) but that the β1 subunit plays the major role in binding of the RGD sequence. These findings provide new insights into the mechanisms, specificity, and topology of integrin-ligand interactions.

Original languageEnglish
Pages (from-to)17283-17292
Number of pages10
JournalJournal of Biological Chemistry
Volume272
Issue number28
DOIs
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

glycyl-arginyl-glycyl-aspartyl-serine
Terminal Repeat Sequences
Fibronectins
Integrins
Monoclonal Antibodies
Topology
Ligands
Peptides
Recombinant Proteins
Epitopes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies : Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. / Mould, A. Paul; Askari, Janet A.; Aota, Shin Ichi; Yamada, Kenneth M.; Irie, Atsushi; Takada, Yoshikazu; Mardon, Helen J.; Humphries, Martin J.

In: Journal of Biological Chemistry, Vol. 272, No. 28, 1997, p. 17283-17292.

Research output: Contribution to journalArticle

Mould, A. Paul ; Askari, Janet A. ; Aota, Shin Ichi ; Yamada, Kenneth M. ; Irie, Atsushi ; Takada, Yoshikazu ; Mardon, Helen J. ; Humphries, Martin J. / Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies : Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 28. pp. 17283-17292.
@article{ec9d37c645b24cc08904dac76308e1d5,
title = "Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies: Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit",
abstract = "The high affinity interaction of integrin α5β1 with the central cell binding domain (CCBD) of fibronectin requires both the Arg-Gly-Asp (RGD) sequence (in the 10th type III repeat) and a second site (in the adjacent 9th type III repeat) which synergizes with RGD. We have attempted to map the fibronectin binding interface on α5β1 using monoclonal antibodies (mAbs) that inhibit ligand recognition. The binding of two anti-α5 mAbs (P1D6 and JBS5) to α5β1 was strongly inhibited by a tryptic CCBD fragment of fibronectin (containing both synergy sequence and RGD) but not by GRGDS peptide. Using recombinant wild type and mutated fragments of the CCBD, we show that the synergy region of the 9th type III repeat is involved in blocking the binding of P1D6 and JBS5 to α5β1. In contrast, binding of the anti-β1 mAb P4C10 to α5β1 was inhibited to a similar extent by GRGDS peptide, the tryptic CCBD fragment, or recombinant proteins lacking the synergy region, indicating that the RGD sequence is involved in blocking P4C10 binding. P1D6 inhibited the interaction of a wild type CCBD fragment with α5β1 but bad no effect on the binding of a mutant fragment that lacked the synergy region. The epitopes of P1D6 and JBS5 mapped to the NH2- terminal repeats of the α5 subunit. Our results indicate that the synergy region is recognized primarily by the α5 subunit (in particular by its NH2- terminal repeats) but that the β1 subunit plays the major role in binding of the RGD sequence. These findings provide new insights into the mechanisms, specificity, and topology of integrin-ligand interactions.",
author = "Mould, {A. Paul} and Askari, {Janet A.} and Aota, {Shin Ichi} and Yamada, {Kenneth M.} and Atsushi Irie and Yoshikazu Takada and Mardon, {Helen J.} and Humphries, {Martin J.}",
year = "1997",
doi = "10.1074/jbc.272.28.17283",
language = "English",
volume = "272",
pages = "17283--17292",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies

T2 - Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit

AU - Mould, A. Paul

AU - Askari, Janet A.

AU - Aota, Shin Ichi

AU - Yamada, Kenneth M.

AU - Irie, Atsushi

AU - Takada, Yoshikazu

AU - Mardon, Helen J.

AU - Humphries, Martin J.

PY - 1997

Y1 - 1997

N2 - The high affinity interaction of integrin α5β1 with the central cell binding domain (CCBD) of fibronectin requires both the Arg-Gly-Asp (RGD) sequence (in the 10th type III repeat) and a second site (in the adjacent 9th type III repeat) which synergizes with RGD. We have attempted to map the fibronectin binding interface on α5β1 using monoclonal antibodies (mAbs) that inhibit ligand recognition. The binding of two anti-α5 mAbs (P1D6 and JBS5) to α5β1 was strongly inhibited by a tryptic CCBD fragment of fibronectin (containing both synergy sequence and RGD) but not by GRGDS peptide. Using recombinant wild type and mutated fragments of the CCBD, we show that the synergy region of the 9th type III repeat is involved in blocking the binding of P1D6 and JBS5 to α5β1. In contrast, binding of the anti-β1 mAb P4C10 to α5β1 was inhibited to a similar extent by GRGDS peptide, the tryptic CCBD fragment, or recombinant proteins lacking the synergy region, indicating that the RGD sequence is involved in blocking P4C10 binding. P1D6 inhibited the interaction of a wild type CCBD fragment with α5β1 but bad no effect on the binding of a mutant fragment that lacked the synergy region. The epitopes of P1D6 and JBS5 mapped to the NH2- terminal repeats of the α5 subunit. Our results indicate that the synergy region is recognized primarily by the α5 subunit (in particular by its NH2- terminal repeats) but that the β1 subunit plays the major role in binding of the RGD sequence. These findings provide new insights into the mechanisms, specificity, and topology of integrin-ligand interactions.

AB - The high affinity interaction of integrin α5β1 with the central cell binding domain (CCBD) of fibronectin requires both the Arg-Gly-Asp (RGD) sequence (in the 10th type III repeat) and a second site (in the adjacent 9th type III repeat) which synergizes with RGD. We have attempted to map the fibronectin binding interface on α5β1 using monoclonal antibodies (mAbs) that inhibit ligand recognition. The binding of two anti-α5 mAbs (P1D6 and JBS5) to α5β1 was strongly inhibited by a tryptic CCBD fragment of fibronectin (containing both synergy sequence and RGD) but not by GRGDS peptide. Using recombinant wild type and mutated fragments of the CCBD, we show that the synergy region of the 9th type III repeat is involved in blocking the binding of P1D6 and JBS5 to α5β1. In contrast, binding of the anti-β1 mAb P4C10 to α5β1 was inhibited to a similar extent by GRGDS peptide, the tryptic CCBD fragment, or recombinant proteins lacking the synergy region, indicating that the RGD sequence is involved in blocking P4C10 binding. P1D6 inhibited the interaction of a wild type CCBD fragment with α5β1 but bad no effect on the binding of a mutant fragment that lacked the synergy region. The epitopes of P1D6 and JBS5 mapped to the NH2- terminal repeats of the α5 subunit. Our results indicate that the synergy region is recognized primarily by the α5 subunit (in particular by its NH2- terminal repeats) but that the β1 subunit plays the major role in binding of the RGD sequence. These findings provide new insights into the mechanisms, specificity, and topology of integrin-ligand interactions.

UR - http://www.scopus.com/inward/record.url?scp=0030798854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030798854&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.28.17283

DO - 10.1074/jbc.272.28.17283

M3 - Article

VL - 272

SP - 17283

EP - 17292

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -